Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
With the potential to address evaporative dry eye, Liposic and Tears Naturale Forte have been developed in which phospholipid liposomes are delivered to the tear film via the surface of the closed eyelid. This study compare the effects of Liposic and Tears Naturale Forte application on the lipid and stability of the tear film in dry eye patients.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Liposic | Experimental | Liposic was applied to one eye of patients in this group |
|
| Tears Naturale Forte | Experimental | Tears Naturale Forte was applied to one eye of patients in this group |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Liposic | Drug | one eye of the participant recieved Lipoic |
|
|
| Measure | Description | Time Frame |
|---|---|---|
| scale of Schirmer I test | up to 3 months after tear substitutes apply | |
| scale of corneal fluorescein staining | up to 3 months after tear substitutes apply | |
| scale of noninvasive tear breakup time | up to 3 months after tear substitutes apply | |
| scale of tear meniscus height | up to 3 months after tear substitutes apply | |
| lipid layer grade | up to 3 months after tear substitutes apply | |
| questionnaire of ocular surface disease index | up to 3 months after tear substitutes apply |
| Measure | Description | Time Frame |
|---|---|---|
| subjective comfort | Subjective comfort was established at each time-point by asking subjects, firstly, to relate their comfort to baseline in each eye (more comfortable/no different/less comfortable) . secondly, to express a preference for their more comfortable eye (right eye/left eye/no difference) | up to 3 months after tear substitutes apply |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Chi Zhang, MD,PhD | Contact | mike0946@163.com |
| Name | Affiliation | Role |
|---|---|---|
| Xingwu Zhong | Zhongshan Ophthalmic Center, Sun Yat-sen University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hainan Eye Hospital, Zhongshan Ophthalmic Center of Sun Yat-sen University | Recruiting | Haikou | Hainan | 570311 | China |
Not provided
| ID | Term |
|---|---|
| D015352 | Dry Eye Syndromes |
| ID | Term |
|---|---|
| D007766 | Lacrimal Apparatus Diseases |
| D005128 | Eye Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| C479038 | carbomer |
| D003911 | Dextrans |
| ID | Term |
|---|---|
| D005936 | Glucans |
| D001704 | Biopolymers |
| D011108 | Polymers |
| D046911 | Macromolecular Substances |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Tears Naturale Forte | Drug | the other eye of the participant recieved Tears Naturale Forte |
|
|
| D011134 |
| Polysaccharides |
| D002241 | Carbohydrates |